Published in Hematology Week, February 9th, 2004
According to a study from Slovenia, AF "is associated with hemostatic abnormalities and increased risk of thrombotic cardiovascular events even during oral anticoagulant therapy (OAT)."
N. Vene and coauthors at the University of Ljubljana evaluated "the predictive value of hemostatic markers for the risk of major cardiovascular events during OAT."
"The study group comprised 113 patients with chronic AF (70.2±5.4 years old, 60% men), referred for OAT," they wrote in the journal Thrombosis and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.